An L1 retrotransposon insertion-induced deafness mouse model for studying the development and function of the cochlear stria vascularis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 34583993.
- Also identified by DOI 10.1073/pnas.2107933118 and PMC identifier 8501756.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dysregulation of ion and potential homeostasis in the scala media is the most prevalent cause of hearing loss in mammals. However, it is not well understood how the development and function of the stria vascularis regulates this fluid homeostasis in the scala media. From a mouse genetic screen, we characterize a mouse line, named <i>299</i>, that displays profound hearing impairment. Histology suggests that <i>299</i> mutant mice carry a severe, congenital structural defect of the stria vascularis. The in vivo recording of <i>299</i> mice using double-barreled electrodes shows that endocochlear potential is abolished and potassium concentration is reduced to ∼20 mM in the scala media, a stark contrast to the +80 mV endocochlear potential and the 150 mM potassium concentration present in healthy control mice. Genomic analysis revealed a roughly 7-kb-long, interspersed nuclear element (LINE-1 or L1) retrotransposon insertion on chromosome 11. Strikingly, the deletion of this L1 retrotransposon insertion from chromosome 11 restored the hearing of <i>299</i> mutant mice. In summary, we characterize a mouse model that enables the study of stria vascularis development and fluid homeostasis in the scala media.
Medical subject headings
- Deafness
- Retroelements
- Stria Vascularis